Guizhou Sanli Pharmaceutical Co.,Ltd.’s Net Profit Rose 167.2% in First Quarter of 2023

Guizhou Sanli Pharmaceutical Co.,Ltd. (贵州三力制药股份有限公司) (603439.SH) reported a net profit of 53.4 million yuan in the first quarter of 2023, up 167.2% year-on-year.

Meanwhile, the company posted 349 million yuan in revenue, up 119.9% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 528 million yuan in total liabilities, with a liability-to-asset ratio of 28%.